↑ 5.05.15.2Shin, O H; Exton J H (August 2001). "Differential binding of arfaptin 2/POR1 to ADP-ribosylation factors and Rac1". Biochem. Biophys. Res. Commun. United States. 285 (5): 1267–73. doi:10.1006/bbrc.2001.5330. ISSN0006-291X. PMID11478794.
↑Tarricone, C; Xiao B; Justin N; Walker P A; Rittinger K; Gamblin S J; Smerdon S J (May 2001). "The structural basis of Arfaptin-mediated cross-talk between Rac and Arf signalling pathways". Nature. England. 411 (6834): 215–9. doi:10.1038/35075620. ISSN0028-0836. PMID11346801.
Tarricone C, Xiao B, Justin N, et al. (2001). "The structural basis of Arfaptin-mediated cross-talk between Rac and Arf signalling pathways". Nature. 411 (6834): 215–9. doi:10.1038/35075620. PMID11346801.
Shin OH, Exton JH (2001). "Differential binding of arfaptin 2/POR1 to ADP-ribosylation factors and Rac1". Biochem. Biophys. Res. Commun. 285 (5): 1267–73. doi:10.1006/bbrc.2001.5330. PMID11478794.
Peters PJ, Ning K, Palacios F, et al. (2002). "Arfaptin 2 regulates the aggregation of mutant huntingtin protein". Nat. Cell Biol. 4 (3): 240–5. doi:10.1038/ncb761. PMID11854752.
Rangone H, Pardo R, Colin E, et al. (2005). "Phosphorylation of arfaptin 2 at Ser260 by Akt Inhibits PolyQ-huntingtin-induced toxicity by rescuing proteasome impairment". J. Biol. Chem. 280 (23): 22021–8. doi:10.1074/jbc.M407528200. PMID15809304.
Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature. 437 (7062): 1173–8. doi:10.1038/nature04209. PMID16189514.